Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2025-12-26 @ 12:18 PM
NCT ID:
NCT01354600
Eligibility Criteria:
Inclusion Criteria:
* Healthy body mass index (BMI) = 19 \< 25 kg/m2
* Obese BMI = 30 \< 35 kg/m2
* Activity level = sedentary: Total energy expenditure/resting metabolic rate \< 1.6 (average US adult level)
Exclusion Criteria:
* Tobacco use
* Regular exercise or physical activity, defined as \> 2h/week of moderate to vigorous activity;
* Individuals who do not eat breakfast
* Weight loss of \> 3% of body weight over the previous six months
* Eating a special diet (e.g., vegetarian or low-carbohydrate)
* Current diagnosis of, or using prescription medications for, thyroid dysfunction, type I or type II diabetes, hypertension, cardiovascular, kidney, or liver disease;
* Taking other prescription medications or over-the-country products that alter energy metabolism (other than birth control pills)
* Allergies to any of the foods used in the study
* Individuals who donated blood within 8 weeks prior to enrollment or who plan to give blood during the course of the study
* Claustrophobia
* History of exercise intolerance, including diagnosed exercise induced asthma or any physical limitations to seated cycling aerobic exercise
* Blood chemistries in excess of 130% of the upper normal level and/or hemoglobin or hematocrit below the normal range.
* Females that are pregnant (pregnancy status to be tested at the beginning of each 6-day metabolic chamber stay), lactating, or have irregular menses
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
39 Years
Study:
NCT01354600
Study Brief:
Protocol Section:
NCT01354600